Atossa Therapeutics
ATOS
#9938
Rank
โ‚น4.64 B
Marketcap
โ‚น539.26
Share price
-6.48%
Change (1 day)
888.59%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2025 (TTM): -โ‚น21.52

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น23.36. In 2024 the company made an earnings per share (EPS) of -โ‚น18.69 an increase over its 2023 EPS that were of -โ‚น22.43.

EPS history for Atossa Therapeutics from 2010 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น21.5215.14%
2024-โ‚น18.69-16.67%
2023-โ‚น22.4314.29%
2022-โ‚น19.6316.67%
2021-โ‚น16.82-90.86%
2020-โ‚น184.12-2.96%
2019-โ‚น189.72-63.09%
2018-โ‚น514.03-49.63%
2017-โ‚น1,021-57.87%
2016-โ‚น2,422-74.01%
2015-โ‚น9,320-9.18%
2014-โ‚น10,262-12.86%
2013-โ‚น11,77670.73%
2012-โ‚น6,89734.08%
2011-โ‚น5,144263.47%
2010-โ‚น1,415

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,041-4,555.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น828.99-3,648.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น984.13-4,312.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น82.24 252.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚น19.63-16.00%๐Ÿ‡บ๐Ÿ‡ธ USA